Latest Breaking News On - ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் - Page 11 : comparemela.com
RIVANNA® Announces Publication of Medtech Innovation Briefing on the Use of Accuro® by United Kingdom s NICE
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
RIVANNA® Announces Publication of Medtech Innovation Briefing on the Use of Accuro® by United Kingdom s NICE
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
‘Our fight for the world’s most expensive drug that could transform our son s life’
Edward was diagnosed at seven weeks with spinal muscular atrophy. His parents are begging authorities for him to get a £1.7m wonder drug
Megan Willis, pictured in her garden in Essex with her seven-month-old son, Edward
Credit: Daniel Jones
Megan Willis was about eight months into her pregnancy when she noticed that her unborn baby was moving a little less than usual. She saw her doctor, who told her that everything looked fine. Willis assumed she was “being paranoid”, and comforted herself with the old wives’ tale that babies become less fidgety as the mother prepares for birth. “I wasn’t panicking, I didn’t think anything was wrong with him,” remembers Willis, 29, an events manager from Essex. Nor did her partner, John Hall, a retail manager.
Alexion and NICE agree confidential discount for Ultomiris use on the NHS
NICE said clinical evidence shows Ultomiris is as effective and safe as Alexion s older PNH drug Soliris
Alexion and the UK’s National Institute for Health and Care Excellence (NICE) have agreed a confidence commercial discount for the paroxysmal nocturnal haemoglobinuria (PNH) treatment Ultomiris for use within the NHS.
The cost-effectiveness watchdog has backed the use of Ultomiris (ravulizumab) to treat PNH in adults with haemolysis with clinical symptoms suggesting high disease activity, or whose disease is clinically stable after receiving Alexion’s older PNH drug Soliris (eculizumab) for six months or more.
NICE publishes new guidance on chronic pain management
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.